Trials / Unknown
UnknownNCT01014325
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Roxall Medizin · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical trial is to assess the safety and efficacy of sublingual application of allergen extracts for specific immunotherapy in patients suffering from perennial allergic rhinitis due to house dust mites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allergen extract | sublingual application |
| BIOLOGICAL | Placebo | sublingual application |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2009-11-16
- Last updated
- 2015-11-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01014325. Inclusion in this directory is not an endorsement.